Fiera Capital (Canada)
ALBO

Fiera Capital (Canada)’s Albireo Pharma Inc ALBO Stock Holding History

Fiera Capital (Canada)’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-126,109
Closed -$2.73M – 535
2022
Q4 		$2.73M Sell
126,109
-2,377
-2% -$50.2K 0.01% 254
2022
Q3 		$1.64M Buy
128,486
+75,088
+141% +$1.55M 0.01% 321
2022
Q2 		$1.06M Buy
+53,398
New +$1.41M ﹤0.01% 398

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fiera Capital (Canada)'s ALBO Position: Q1 2023 in Review

Fiera Capital (Canada) sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 126,109 shares — an estimated $2.73M sold.

Fiera Capital (Canada) first reported a position in ALBO in Q2 2022 and held it in 3 quarters. The position peaked at $2.73M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Fiera Capital (Canada) reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Fiera Capital (Canada) sold 126,109 Albireo Pharma Inc shares in Q1 2023, an estimated $2.73M.
  • Fiera Capital (Canada) first reported a position in Albireo Pharma Inc in Q2 2022 and held it in 3 quarters.
  • Fiera Capital (Canada)'s Albireo Pharma Inc position peaked at $2.73M in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2023, filed 26 Apr 2023.